Veterinary Medicines Information website

Uriphex 50 mg/ml, oral solution for dogs

Authorised
  • Phenylpropanolamine hydrochloride
Download as PDF

Product identification

Medicine name:
Uriphex 50 mg/ml, oral solution for dogs
Active substance:
  • Phenylpropanolamine hydrochloride
Target species:
  • Dog (bitch)
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Phenylpropanolamine hydrochloride
    50.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral solution
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QG04BX91
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Denmark
Package description:
  • HDPE bottle closed with white polypropylene child-resistant cap and LDPE syringe adaptor. A 1 mL HDPE/polypropylene graduated syringe is supplied with each bottle. Bottle of 30 mL.
  • HDPE bottle closed with white polypropylene child-resistant cap and LDPE syringe adaptor. A 1 mL HDPE/polypropylene graduated syringe is supplied with each bottle. Bottle of 60 mL.
  • HDPE bottle closed with white polypropylene child-resistant cap and LDPE syringe adaptor. A 1 mL HDPE/polypropylene graduated syringe is supplied with each bottle. Bottle of 100 mL.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 18 of Regulation (EU) 2019/6)
Marketing authorisation holder:
  • Alfasan Nederland B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Alfasan Nederland B.V.
Responsible authority:
  • Danish Medicines Agency
Authorisation number:
  • 67602
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0383/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Danish (, ORAL OPLØSNING 50 MG-ML)
Published on: 14/03/2026
Download

Combined File of all Documents

English (PDF)
Published on: 31/08/2023
Updated on: 14/03/2026
Download